期刊文献+

嗜酸性粒细胞增多性皮炎11例临床分析 被引量:10

Clinical Analysis on 11 Cases of hypereosinophilic Dermatitis
暂未订购
导出
摘要 目的探讨嗜酸性粒细胞增多性皮炎的临床特点。方法回顾性分析嗜酸性粒细胞增多性皮炎患者的临床资料。结果11例患者中男8例、女3例,平均年龄(51.3±16.7)岁,病程7个月~17年。皮疹泛发、多形、剧痒,伴有一定系统损害。糖皮质激素治疗有效,甘草制剂有一定疗效,部分患者多种治疗抵抗。结论嗜酸性粒细胞增多性皮炎患者多发于男性,甘草制剂有一定疗效。 Objective To analyze the clinical characteristics of hypereosinophilic dermatitis. Methods A retrospective review was done on the medical records of all patients hospitalized due to hypereosinophilic dermatitis. All of the relevant clinical, laboratory and imaging data were analyzed. Results 11 patients in the study (8 males and 3 females, mean age 51.3±16.7 years) showed polymorphic skin lesions, presenting with a combination of erythematous, urticarial papules, plagues and pruritic. The visceral organs could be involved in the disease. Some cases were observed good response to therapy with corticosteroids, others might be responsive to compound glycyrrhizin injection. Therapy-resistant was observed in some cases. Conclusion Most patients of hypereosinophilic dermatitis are male. Compound glycyrrhizin injection may take effect.
出处 《中国中西医结合皮肤性病学杂志》 CAS 2008年第3期175-176,共2页 Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine
关键词 嗜酸性粒细胞增多性皮炎 甘草制剂 临床分析 hypereosinophilic dermatitis compound glycyrrhizin injection clinical analysis
  • 相关文献

参考文献10

二级参考文献22

  • 1[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 2[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 3[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double-blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 4[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 5[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 6[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 7[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 8[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.
  • 9[9]Tsabota A. Corrbinecl ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis C virus infection:a randomized controlled trial in 170patients[J].Eur J Gastroenterd Hepatol, 1999, 11(10):1 077.
  • 10[10]Shiota G, Harada K, Ishida M, et al. Inhibition of hepatocellularcarcinoma by glycyrrhizin in diethylnitrosa-mine-treated mice[J]. Carcinogenesis, 1999,20(1):59.

共引文献142

同被引文献39

引证文献10

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部